Titan Pharmaceuticals Raises $5.5M Via Equity

Titan Pharmaceuticals Inc TTNP has announced a private placement of 3.37 million shares and 1.29 million pre-funded warrants.

  • In addition, the Company has agreed to issue to the investor unregistered warrants to purchase up to an aggregate of 4.67 million shares.
  • The combined offering price of each share or pre-funded warrant and each warrant will be $1.18
  • The warrants will be immediately exercisable, will expire on the five-year and six-month anniversary of the issuance date, and will have an exercise price of $1.14 per share.
  • The aggregate gross proceeds to the Company are expected to be approximately $5.5 million. 
  • The offerings are expected to close by February 4.
  • Maxim Group LLC is acting as the exclusive placement agent in connection with the offerings.
  • Titan Pharmaceuticals commenced exploring and evaluating strategic alternatives in December and engaged Maxim Group as its exclusive financial advisor.
  • Price Action: TTNP shares are down 6.14% at $1.07 during the market session on the last check Wednesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: BiotechNewsPenny StocksHealth CareFinancingOfferingsMoversTrading IdeasGeneralBriefswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!